Kailee Rainse / startuprise - Lund-based Lithea, a biotech company developing targeted cancer treatments that deliver drugs directly into tumours, has raised €851,000 from existing investors to advance its drug delivery system and prepare its lead candidate, LIT1001, for clinical tria…
Back to Top / Monday, October 27, 2025, 6:20 am / permalink 15437 / 2 stories in 4 months
Amplifold clinches €5M to drive rapid diagnostics with DNA-origami technology / 2 months
Adaptam Therapeutics secures €3M for cancer immunotherapy research / 4 months
QT Sense raises €4M for real‐time cellular stress monitoring / 4 wks
FluoSphera secures seed funding for 3D organ model innovation / 7 wks
Swiss startup Liom secures €13.9M for innovative glucose monitoring wearable / 2 months
Lucis secures multi‐million seed round to transform Europe’s preventive healthcare / 2 months
Cellcolabs secures $12M for stem cell therapy scale-up / 4 months
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.